FALEC was expected to be a potential therapeutic target and molecular marker for CCA, and the FALEC / miR-20a-5p / SHOC2 axis regulatory network may provide a potential novel therapeutic strategy for the treatment of CCA. Here, SHOC2 is linked to cholangiocarcinoma.